Frontotemporal Degeneration
14
8
8
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Voices Of Individuals: Challenges and Experiences Of bvFTD
In Vivo PET of Synaptic Density in Cognitive Disorders
The Swedish BioFINDER - Memory Clinic Study
The Swedish BioFINDER - Primary Care Study
The Swedish BioFINDER 2 Study
IL-2 Plus Abatacept in FTD
Telehealth-enabled Integrated Palliative Care for People With Dementia
Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
Advances in Telephone-based Cognitive Screening Procedures
Clearance Mechanisms in Atypical Neurodegenerative Diseases
Cognitive Impairement In Frontotemporal Dementia
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls